Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Igelösa Life Science Aktiebolag
AB
Active
Org 5565549903
Björnstorp, 247 98
Genarp
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 1998
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Igelösa Life Science Aktiebolag
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
3M
6M
9M
13M
10M
2020
9M
2021
11M
2022
7M
2023
8M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
-1M
2020
-2M
2021
1M
2022
0M
2023
0M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
10 435
9 497
11 063
7 019
8 138
Staff expenses
—
—
—
—
—
EBITDA
−859
−1 982
1 371
449
180
Depreciation & amort.
−360
−232
−334
−243
−190
EBIT
−1 219
−2 214
1 037
206
−10
Net financials
3 848
3 487
476
664
817
Profit before tax
1 914
1 273
1 513
870
1 522
Tax
−459
353
−367
−230
−384
Net profit
1 455
1 626
1 146
640
1 138
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
32 298
34 650
34 274
35 180
35 466
Equity
29 004
30 629
31 775
32 415
33 553
Long-term debt
0
0
0
0
0
Short-term debt
2 579
3 306
1 784
2 050
1 913
Total debt
2 579
3 306
1 784
2 050
1 913
Financial ratios
5-year trend
EBITDA margin
2.2%
This company
15.8%
Market median
-86% vs market
2020
2024
Equity ratio
94.6%
This company
38.2%
Market median
+148% vs market
2020
2024
Return on equity
3.4%
This company
18.4%
Market median
-82% vs market
2020
2024
Net profit margin
14.0%
This company
8.1%
Market median
+73% vs market
2020
2024
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
2020
2024
Debt / equity
0.06×
This company
0.62×
Market median
+90% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Igelösa Life Science Aktiebolag
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
